Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pankaj Ramanbhai Patel HUF28-03-2018
28-03-2018
Disclosure Under Regulation 29(2) Of The SEBI SAST Regulations, 2011
Disclosure under regulation 29(2) of the SEBI SAST Regulations, 201128-03-2018
Zydus Cadila gets USFDA nod for cardiac drug
Zydus Cadila has received final approval from USFDA to market Metoprolol Succinate extended-release tablets USP26-03-2018
Volume Shockers today: Cadila Healthcare, Unichem, Gulf Oil Lubricants, Chambal Fertilizers
Cadila Healthcare is one of the stocks dominating the volume shockers screener today, gaining after the company said Zydus Cadila has received final approval from the US regulator for Metoprolol Succinate extended-release tablets. The drug is used to treat chest pain, heart failure and high blood pressure. Other volume shockers today include Unichem Labs, as well as Chambal Fertilizers.26-03-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Metoprolol Succinate Extended-Release Tablets USP26-03-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Omeprazole and Sodium Bicarbonate Capsules.17-03-2018
Zydus Cadila gets USFDA nod for Tizanidine tablets
Cadila Healthcare today said its group firm Zydus Cadila has received final approval from the US health regulator for its generic version of Tizanidine tablets used for treatment of muscle spasms13-03-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Tizanidine Tablets USP13-03-2018
Zydus Cadila partners Medicure to launch cholesterol drug in US
Drug firm Zydus Cadila has entered into a definitive agreement with US-based Medicure International Inc to commercialise its new drug application product pitavastatin magnesium in the US. The la08-03-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.08-03-2018